154 related articles for article (PubMed ID: 26399160)
1. Brimonidine Induced Anterior Uveitis.
Beltz J; Zamir E
Ocul Immunol Inflamm; 2016; 24(2):128-33. PubMed ID: 26399160
[TBL] [Abstract][Full Text] [Related]
2. Brimonidine-associated uveitis - a descriptive case series.
Hopf S; Mercieca K; Pfeiffer N; Prokosch-Willing V
BMC Ophthalmol; 2020 Dec; 20(1):489. PubMed ID: 33334316
[TBL] [Abstract][Full Text] [Related]
3. Hypertensive acute granulomatous anterior uveitis as a side effect of topical brimonidine.
Clemente-Tomás R; Arciniegas-Perasso CA; Hervás-Hernandis JM; García-Ibor F; Ruiz-Del Río N; Duch-Samper AM
Arch Soc Esp Oftalmol (Engl Ed); 2018 Oct; 93(10):511-514. PubMed ID: 29910082
[TBL] [Abstract][Full Text] [Related]
4. Brimonidine-induced anterior uveitis and conjunctivitis: clinical and histologic features.
Nguyen EV; Azar D; Papalkar D; McCluskey P
J Glaucoma; 2008; 17(1):40-2. PubMed ID: 18303383
[TBL] [Abstract][Full Text] [Related]
5. Anterior uveitis as a side effect of topical brimonidine.
Byles DB; Frith P; Salmon JF
Am J Ophthalmol; 2000 Sep; 130(3):287-91. PubMed ID: 11020406
[TBL] [Abstract][Full Text] [Related]
6. Drugs, Inflammation, and the Eye.
Cunningham ET; London NJ; Moorthy R; Garg SJ; Zierhut M
Ocul Immunol Inflamm; 2016; 24(2):125-7. PubMed ID: 27074544
[No Abstract] [Full Text] [Related]
7. Brimonidine-timolol fixed combination induced granulomatous inflammation of the eye.
Carrasco MA; Schlaen BA; Zárate JO
Int Ophthalmol; 2013 Oct; 33(5):557-60. PubMed ID: 23224363
[TBL] [Abstract][Full Text] [Related]
8. [Anterior uveitis and topical brimonidine: a case report].
Velasque L; Ducousso F; Pernod L; Vignal R; Deral V
J Fr Ophtalmol; 2004 Dec; 27(10):1150-2. PubMed ID: 15687926
[TBL] [Abstract][Full Text] [Related]
9. Bilateral granulomatous uveitis in an elderly female.
Kattige J; Konana VK; Babu K
Indian J Ophthalmol; 2019 Sep; 67(9):1391. PubMed ID: 31436179
[No Abstract] [Full Text] [Related]
10. [Brimonidine and acute anterior granulomatous uveitis: A case report and literature review].
Comet A; Donnadieu B; Courjaret JC; Gascon P; Denis D; Matonti F
J Fr Ophtalmol; 2017 Apr; 40(4):e127-e129. PubMed ID: 28336279
[No Abstract] [Full Text] [Related]
11. Suspected granulomatous anterior uveitis associated with brimonidine tartrate 0.2% and timolol maleate 0.5% ophthalmic solution.
Casado A; Cabarga C; de la Fuente MA; Muñoz-Negrete FJ
Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2659-60. PubMed ID: 23835755
[No Abstract] [Full Text] [Related]
12. Granulomatous anterior uveitis associated with 0.2% topical brimonidine.
Cates CA; Jeffrey MN
Eye (Lond); 2003 Jul; 17(5):670-1. PubMed ID: 12855989
[No Abstract] [Full Text] [Related]
13. Brimonidine induced bilateral hypertensive anterior uveitis: Case report and review of the literature.
Boualila L; Bouirig K; El Hamidi S; Boutimzine N; Cherkaoui LO
J Fr Ophtalmol; 2023 May; 46(5):e143-e145. PubMed ID: 36804117
[No Abstract] [Full Text] [Related]
14. Drug-induced ocular inflammation.
Samalia P; Sims J; Niederer R
N Z Med J; 2020 Dec; 133(1527):83-94. PubMed ID: 33332330
[TBL] [Abstract][Full Text] [Related]
15. A case of bilateral deep stromal corneal opacity and vascularization after use of multiple antiglaucoma medications including brimonidine tartrate ophthalmic solution.
Tsujinaka A; Takai Y; Inoue Y; Tanito M
Acta Ophthalmol; 2019 Sep; 97(6):e948-e949. PubMed ID: 30609169
[No Abstract] [Full Text] [Related]
16. Vitreous and aqueous concentrations of brimonidine following topical application of brimonidine tartrate 0.1% ophthalmic solution in humans.
Takamura Y; Tomomatsu T; Matsumura T; Takihara Y; Kozai S; Arimura S; Yokota S; Inatani M
J Ocul Pharmacol Ther; 2015 Jun; 31(5):282-5. PubMed ID: 25918904
[TBL] [Abstract][Full Text] [Related]
17. Anterior uveitis and concurrent allergic conjunctivitis associated with long-term use of topical 0.2% brimonidine tartrate.
Becker HI; Walton RC; Diamant JI; Zegans ME
Arch Ophthalmol; 2004 Jul; 122(7):1063-6. PubMed ID: 15249377
[No Abstract] [Full Text] [Related]
18. Effect of Brimonidine on the B Cells, T Cells, and Cytokines of the Ocular Surface and Aqueous Humor in Rat Eyes.
Shin HY; Lee HS; Lee YC; Kim SY
J Ocul Pharmacol Ther; 2015 Dec; 31(10):623-6. PubMed ID: 26401980
[TBL] [Abstract][Full Text] [Related]
19. Three-month randomized trial of fixed-combination brinzolamide, 1%, and brimonidine, 0.2%.
Katz G; Dubiner H; Samples J; Vold S; Sall K
JAMA Ophthalmol; 2013 Jun; 131(6):724-30. PubMed ID: 23579344
[TBL] [Abstract][Full Text] [Related]
20. Allergic contact dermatitis to topical brimonidine.
Rajagopalan A; Rajagopalan B
Australas J Dermatol; 2015 Aug; 56(3):235. PubMed ID: 26201375
[No Abstract] [Full Text] [Related]
[Next] [New Search]
